Multivariate regression analysis of predictors for overall mortality in patients with severe and non-severe aortic valve stenosis (AVS)
| HR | 95% CI | p Value | |
| (a) Predictive outcome variables in patients with severe AVS (group A) | |||
| PAP | 1.05 | 1.03 to 1.07 | <0.001 |
| STS-PROM | 1.01 | 0.9 to 1.03 | 0.03 |
| Serum creatinine | 1.59 | 1.15 to 2.19 | 0.005 |
| Diabetes | 2.04 | 1.17 to 3.59 | 0.013 |
| (b) Predictive outcome variables in patients with non-severe AVS (group B) | |||
| LVEF | 0.95 | 0.92 to 0.99 | 0.027 |
| PAP | 1.03 | 1.01 to 1.05 | 0.002 |
| Serum creatinine | 2.1 | 1.14 to 3.89 | 0.017 |
| β-Blocker | 0.19 | 0.08 to 0.47 | <0.001 |
| ACE inhibitor | 0.49 | 0.22 to 1.11 | 0.08 |
AVA, aortic valve area; LVEF, left ventricular ejection fraction; PAP, pulmonary artery pressure; STS-PROM, Society of Thoracic Surgeons Predicted Risk Of Mortality;